以色列2017–2018年甲型肝炎强化监测的经验
以色列在幼儿普遍接种疫苗后甲型肝炎地方性流行极低,但仍有散发性暴发。2017–2018年实施综合监测:对anti-HAV IgM阳性疑似病例血清做分子确认和基因分型,并采集以色列和巴勒斯坦污水样本进行分子分析,结合临床与流行病学数据评估。共研究146例病例和240份污水样本,2017年以基因1A型为主并与全球MSM暴发相关,2018年以基因1B型为主并与既往地方株相关,环境分析显示污水与病例序列聚类且全国范围传播。
要点
- 病例与污水样本的分子分型结合临床流行病学数据可提升甲肝监测。
- 2017年基因1A型与全球MSM甲肝暴发相关,2018年转为基因1B型地方株。
- 环境污水测序可揭示甲肝病毒全国范围传播和序列聚类。
核心结论
- 对病例和环境样本进行分子确认与测序分型,结合临床和流行病学调查,可能改善甲型肝炎监测。
- 临床与污水来源样本的序列分型有助于理解病毒传播。
研究设计与样本
- 2017和2018年,将疑似甲肝病例中anti-HAV IgM抗体阳性的血清转至中央病毒学实验室进行分子确认和基因分型。
- 在以色列和巴勒斯坦采集污水样本并进行分子分析。
- 合并中央病毒学实验室分子数据、地区卫生办公室和流行病学部门数据及治疗医生临床数据,进行一致性评估。
主要发现
- 共研究146例病例(2017年78例,2018年68例,中位年龄34岁,102例男性)和240份污水样本。
- 大多数病例(96%)未接种疫苗。
- 2017年89%的病例为男性,其中45%为男男性行为者(MSM);2018年49%为男性,但其中仅3%为MSM(p < 0.01)。
- 2017年82%的病例和63%的污水样本为基因1A型,系统发育上与全球MSM甲肝暴发相关。
- 2018年80%的病例和71%的污水样本为基因1B型,与先前在以色列和巴勒斯坦鉴定的地方性毒株相关。
临床怎么用
- 对疑似甲肝病例的IgM阳性血清应转送参考实验室做分子确认和基因分型。
- 将污水环境监测与病例分子分型结合,用于追踪甲肝病毒传播和识别暴发来源。
- 结合临床、流行病学和分子数据综合评估,以指导甲肝防控。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IntroductionUniversal vaccination of toddlers has led to very low hepatitis A (HAV) endemicity in Israel. However, sporadic outbreaks still occur, necessitating better surveillance.AimTo implement a comprehensive HAV surveillance programme.MethodsIn 2017 and 2018, sera from suspected HAV cases that tested positive for anti-HAV IgM antibodies were transferred to the Central Virology Laboratory (CVL) for molecular confirmation and genotyping. Sewage samples were collected in Israel and Palestine* and were molecularly analysed. All molecular (CVL), epidemiological (District Health Offices and Epidemiological Division) and clinical (treating physicians) data were combined and concordantly assessed.ResultsOverall, 146 cases (78 in 2017 and 68 in 2018, median age 34 years, 102 male) and 240 sewage samples were studied. Most cases (96%) were unvaccinated. In 2017, 89% of cases were male, 45% of whom were men who have sex with men (MSM). In 2018, 49% were male, but only 3% of them were MSM (p < 0.01). In 2017, 82% of cases and 63% of sewage samples were genotype 1A, phylogenetically associated with a global MSM-HAV outbreak. In 2018, 80% of cases and 71% of sewage samples were genotype 1B, related to the endemic strain previously identified in Israel and Palestine*. Environmental analysis revealed clustering of sewage and cases' sequences, and country-wide circulation of HAV.ConclusionsMolecular confirmation of HAV infection in cases and analysis of environmental samples, combined with clinical and epidemiological investigation, may improve HAV surveillance. Sequence-based typing of both clinical and sewage-derived samples could assist in understanding viral circulation.
引用
- Gozlan Y, Bar-Or I, Volnowitz H, et al. Lessons from intensified surveillance of viral hepatitis A, Israel, 2017 and 2018. Euro Surveill. 2021. PMID: 33573709. doi:10.2807/1560-7917.ES.2021.26.6.2000001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。